PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 23, 2026, 9:17 PM ET

Sponsor Check › Issuer

KANGAROO BIOMED A SERIES OF VUVP FUND LLC

Limited Liability Company · organized in DELAWARE · formed 2025 · AUSTIN, TX · SEC CIK 2056178

2Form D filings
$445,870max total sold reported
49investors (max reported)
2025–2026filing years
0new offerings, last 12 mo

Data last updated: Oct 23, 2026, 5:45 PM ET · Latest filing by this issuer: Oct 19, 2026 · Courts (RECAP) last checked: not yet · SEC enforcement last checked: not yet

Key records

The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.

1. Lawsuits

Not yet searched.

Sources to be searched: CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.

2. Regulatory actions

Not yet searched.

Sources to be searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. State securities regulator actions: not yet searched. · Search queued. Results are added automatically; check back later or follow this page to be notified.

3. Bankruptcies

Not yet searched.

Sources to be searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.

4. Differences between public sources

Coming soon.

What will be compared: what the sponsor says publicly (website, marketing materials, claimed profile) against what public records show — SEC Form D filings, Form ADV adviser registration, and state business records. Every comparison is reviewed by a person before it is published.

No comparisons published yet.

Sources to be compared: sponsor public claims · SEC Form D · SEC Form ADV (IAPD) · state business records · As of Oct 23, 2026, 9:17 PM ET.

5. Money to insiders and sales commissions

0 of 1 offering report sales commissions; 0 report finder's fees; 1 reports proceeds to related persons totalling $84,562. (includes amounts the issuer reported as estimates)

SourceOffering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell it
EDGAR ↗Oct 19, 2026 D/A
File 021-544394
$0$0$84,562 (est.)
This estimated amount represents a one-time cost to cover fund organization and operating expenses.
None listed

As reported by the issuer on Form D (Items 12–15), latest filing per offering. "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates.

Offerings (SEC Form D)

Each filing as reported by the issuer. Open a row for the full plain-English detail.

Oct 19, 2026 D/A Pooled Investment Fund — $445,870 sold of $445,870 · 49 investors EDGAR ↗
FilingForm D/A (amendment) filed Oct 19, 2026 · amends 0002056178-25-000001 ↗
SEC file no. 021-544394 · accession 0002056178-26-000002
Raise progress$445,870 sold of $445,870 offered (100%) · $0 remaining
Filing timingDate of first sale: Jan 24, 2025 · Form D filed: Oct 19, 2026 (633 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale638 days (1.7 years)
Annual amendmentsIssuer reported the offering may last more than one year. This filing is an amendment dated Oct 19, 2026.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors49 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed; Investment Company Act 3C exclusion; Investment Company Act 3C.1 exclusion
Minimum investment accepted$2,360
Securities offeredPooled investment fund interests
Industry / issuer sizePooled Investment Fund (Venture Capital Fund) · revenue range: Decline to Disclose
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $84,562 (est.)
This estimated amount represents a one-time cost to cover fund organization and operating expenses.
Signed byMelissa Garlough, Officer of the Issuer's Admin Manager (Oct 19, 2026)
Changes vs prior filingtotal sold: $283,470 → $445,870
total offering: $283,470 → $445,870
investors: 32 → 49
minimum investment: $5,000 → $2,360
proceeds to insiders: $54,194 → $84,562
industry: Other → Pooled Investment Fund
Compared with the D filed Apr 24, 2025 (EDGAR ↗). Amendment history as filed; no conclusion is drawn.
Market contextMinimum investment: $2,360. Typical range for similar offerings: $1,000–$100,000.
Offering size: $445,870. Typical range: $155,000–$5,250,000.
Investors: 49. Typical range: 4–27.
"Similar" = Pooled Investment Fund offerings claiming 506(b) filed in the last 5 years (83,801 filings); ranges are the middle half (25th–75th percentile). No ranking or score.
SourceThis filing on SEC EDGAR ↗ · retrieved from the EDGAR daily index
Apr 24, 2025 D Other — $283,470 sold of $283,470 · 32 investors EDGAR ↗
FilingForm D filed Apr 24, 2025
SEC file no. 021-544394 · accession 0002056178-25-000001
Raise progress$283,470 sold of $283,470 offered (100%) · $0 remaining
Filing timingDate of first sale: Jan 24, 2025 · Form D filed: Apr 24, 2025 (90 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale638 days (1.7 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors32 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed; Investment Company Act 3C exclusion; Investment Company Act 3C.1 exclusion
Minimum investment accepted$5,000
Securities offeredPooled investment fund interests
Industry / issuer sizeOther · revenue range: Decline to Disclose
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $54,194 (est.)
This estimated amount represents a one-time cost to cover fund organization and operating expenses.
Signed byMelissa Garlough, Officer of the Issuer's Manager (Apr 24, 2025)
Market contextMinimum investment: $5,000. Typical range for similar offerings: $5,000–$50,000.
Offering size: $283,470. Typical range: $500,000–$7,000,000.
Investors: 32. Typical range: 2–14.
"Similar" = Other offerings claiming 506(b) filed in the last 5 years (18,678 filings); ranges are the middle half (25th–75th percentile). No ranking or score.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set

All Form D filings for this CIK on SEC EDGAR ↗. History: 0 new offerings in the last 12 months · most recent filing Oct 19, 2026 · industry as reported over time: Other → Pooled Investment Fund.

Key people (related persons as listed on Form D)

NameRelationshipAddress stateOn filingsAlso listed on
Finally Fund Admin entityDirector
Issuer's Admin Manager
TXApr 24, 2025 → Oct 19, 2026279 other issuers
Joseph FernandesExecutive Officer
Managing Director of the Issuer
TXApr 24, 2025 → Oct 19, 20265 other issuers
Melissa GarloughExecutive Officer
Officer of the Issuer's Admin Manager
TXApr 24, 2025 → Oct 19, 2026221 other issuers

Executive officers, directors and promoters as self-reported by the issuer. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗.

Connections

Other issuers listing the same people:

Shared address: this business address appears on filings for 146 other issuers. Stated as a count only — many addresses are shared office buildings or registered agents.

Adviser registration (Form ADV)

Not yet searched. Sources to be searched: SEC Investment Adviser Public Disclosure (IAPD) firm search — registered and exempt reporting advisers · Search queued. Results are added automatically; check back later.

Public profiles

Not yet collected. We store official links only (company website, verified via a profile claim) and the earliest archived date of the website; never personal or family accounts.

Export this report as PDF (all source links + data timestamp; members)

Change history

No corrections have been requested for this page.

Facts from public records only, each linked to its source. No ratings, no opinions. Request a correction · Claim this profile · Facts policy

Email me the full report

The complete public-record profile for KANGAROO BIOMED A SERIES OF VUVP FUND LLC, plus the weekly new-filings list.

What do you want to do?

Only "Connect me" shares your details — with this sponsor, at a flat price we charge them, never tied to whether you invest. "Just researching" shares nothing.

Request a correction

Free. Tell us what's wrong and, if you can, where the correct public record is. Every request is logged with its status (received → under review → fixed / confirmed with source).

Sponsor response

Sponsors may add a sourced explanation next to any fact on this page. Reviewed before publishing; never edits the public record.

Claim this profile (sponsors)

Free. Get the "Claimed by sponsor" chip and a verified contact for corrections. Claiming never changes the public-record section.